James C. Mullen
2008
In 2008, James C. Mullen earned a total compensation of $11.3M as Former President and CEO at Biogen, a 7% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $96,352 |
|---|---|
| Non-Equity Incentive Plan | $2,400,000 |
| Option Awards | $3,627,275 |
| Salary | $1,192,308 |
| Stock Awards | $3,750,132 |
| Other | $257,919 |
| Total | $11,323,986 |
Mullen received $3.8M in stock awards, accounting for 33% of the total pay in 2008.
Mullen also received $96.4K of change in pension value and nonqualified deferred compensation earnings, $2.4M in non-equity incentive plan, $3.6M in option awards, $1.2M in salary and $257.9K in other compensation.
Rankings
In 2008, James C. Mullen's compensation ranked 211th out of 9,135 executives tracked by ExecPay. In other words, Mullen earned more than 97.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 211 out of 9,135 | 98th |
Division Manufacturing | 63 out of 3,436 | 98th |
Major group Chemicals And Allied Products | 10 out of 815 | 99th |
Industry group Drugs | 8 out of 597 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 118 | 98th |
Source: SEC filing on April 21, 2011.
Mullen's colleagues
We found three more compensation records of executives who worked with James C. Mullen at Biogen in 2008.